Novel Combo With Engineered NK Cells in Early Trial for Breast Cancer

(MedPage Today) -- At the San Antonio Breast Cancer Symposium, Margaret Gatti-Mays, MD, MPH, of the Ohio State University in Columbus, discussed the ongoing phase Ib/II DiG NKs trial, which is assessing gemcitabine, transforming growth factor beta...